Conclusion
hypertension, OA, osteoarthritic
HYPERTENSION
The genetic prediction of PSDs and aldosterone antagonists suggested their protective effects against OA, providing essential guidance for the redevelopment of current drugs and therapy for hypertension in osteoarthritic patients. Nonetheless, additional high-quality research is still necessary for confirmation.